![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Media library & contacts - Merck.com
Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)
History - Merck.com
Learn how Merck has created a legacy of inventing medicines and vaccines and become a leading global biopharmaceutical company over the past 130 years.
Company fact sheet - Merck.com
Dec 31, 2023 · Merck is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. View the list of products marketed in the U.S.
Media - Merck.com
Jan 27, 2025 · Merck's online newsroom offers real-time news about Merck's prescription medicines, vaccines and consumer care products.
Merck to Acquire Imago BioSciences, Inc. - Merck.com
Nov 21, 2022 · RAHWAY, N.J. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO) today announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago for $36.00 per share ...
Who we are - Merck.com
Merck aspires to be the premier research-intensive biopharmaceutical company in the world. Learn about our commitment to save and improve lives.
Events & presentations - Merck
Explore Merck's investor events and presentations. Merck is the world's premier research-intensive, purpose-driven biopharmaceutical company.
Products list - Merck.com
For information about Merck’s products and services including the reporting of an Adverse Event or Product Quality Complaint with a specific Merck product, please call the Merck National Service Center.
Merck Enters into Exclusive Global License Agreement with …
Dec 18, 2024 · Under the agreement, Hansoh Pharma has granted Merck an exclusive global license to develop, manufacture and commercialize HS-10535. Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments associated with the development, regulatory approval and commercialization of the ...